Nikolaos Zamboglou

Limassol, Cyprus

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

High-dose-rate monotherapy for localised prostate Cancer: A two-implant approach with median 13 years follow-up.

High-dose-rate monotherapy for localised prostate Cancer: A two-implant approach with median 13 years follow-up.

Journal: Clinical and translational radiation oncology

Published: May 08, 2026

Dosimetric comparison of AcurosTM BV and AAPM TG-43 formalism for interstitial iridium-192 high-dose-rate brachytherapy.

Dosimetric comparison of AcurosTM BV and AAPM TG-43 formalism for interstitial iridium-192 high-dose-rate brachytherapy.

Journal: Journal of contemporary brachytherapy

Published: January 16, 2024

Narrative Review of High-Dose-Rate Interstitial Brachytherapy in Primary or Secondary Liver Tumors.

Narrative Review of High-Dose-Rate Interstitial Brachytherapy in Primary or Secondary Liver Tumors.

Journal: Frontiers in oncology

Published: October 24, 2021

MR relaxation times of agar-based tissue-mimicking phantoms.

MR relaxation times of agar-based tissue-mimicking phantoms.

Journal: Journal of applied clinical medical physics

Published: September 29, 2021

High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up.

High-Dose-Rate Brachytherapy as Monotherapy for Low- and Intermediate-Risk Prostate Cancer. Oncological Outcomes After a Median 15-Year Follow-Up.

Journal: Frontiers in oncology

Published: September 05, 2021

Simple methods to test the accuracy of MRgFUS robotic systems.

Simple methods to test the accuracy of MRgFUS robotic systems.

Journal: The international journal of medical robotics + computer assisted surgery : MRCAS

Published: February 23, 2021

High-dose-rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome.

High-dose-rate brachytherapy for prostate cancer: Rationale, current applications, and clinical outcome.

Journal: Cancer reports (Hoboken, N.J.)

Published: December 13, 2020

Computed tomography guided interstitial percutaneous high-dose-rate brachytherapy in the management of lung malignancies. A review of the literature.

Computed tomography guided interstitial percutaneous high-dose-rate brachytherapy in the management of lung malignancies. A review of the literature.

Journal: Brachytherapy

Published: September 30, 2020

PET/CT imaging of prostate cancer in the era of small molecule prostate specific membrane antigen targeted tracers.

PET/CT imaging of prostate cancer in the era of small molecule prostate specific membrane antigen targeted tracers.

Journal: Hellenic journal of nuclear medicine

Published: August 07, 2020

Intraluminal High-Dose-Rate Brachytherapy-An Alternative Organ-Preserving Approach for Primary Male Urothelial Carcinoma With Panurethral Involvement.

Intraluminal High-Dose-Rate Brachytherapy-An Alternative Organ-Preserving Approach for Primary Male Urothelial Carcinoma With Panurethral Involvement.

Journal: Practical radiation oncology

Published: July 08, 2019

Image-guided interstitial high-dose-rate brachytherapy for dose escalation in the radiotherapy treatment of locally advanced lung cancer: A single-institute experience.

Image-guided interstitial high-dose-rate brachytherapy for dose escalation in the radiotherapy treatment of locally advanced lung cancer: A single-institute experience.

Journal: Brachytherapy

Published: March 22, 2019

Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme.

Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme.

Journal: Journal of contemporary brachytherapy

Published: December 10, 2018

Showing 1-12 of 33

Last Updated: 09/26/2026